首页 › 肺癌 › 佛罗里达州 › Plantation
Plantation FL 肺癌临床试验
7项针对 肺癌的研究正在 Plantation及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- BRCR Global, Plantation
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
招募中3 期
- Florida Clinical Trials Group Plantation, Plantation
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- BRCR Global, Plantation
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
招募中3 期
- Florida Clinical Trials Group, LLC, Plantation
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- Boca Raton Clinical Research Associates, Plantation
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Washington, DC41 项研究
- Arlington, VA41 项研究
- Chicago, IL41 项研究
- Nashville, TN40 项研究
- Baltimore, MD40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
Plantation的其他研究
- 非小细胞肺癌16 项研究
- 乳腺癌14 项研究
- 狼疮7 项研究
- 癌症(所有类型)7 项研究
- 类风湿关节炎6 项研究
- 转移性癌症6 项研究
- 结直肠癌5 项研究
- 银屑病关节炎5 项研究
- 前列腺癌5 项研究
- 头颈鳞状细胞癌4 项研究
- 多发性骨髓瘤4 项研究
- 黑色素瘤4 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。